North American Pharma-Biotech Construction Starts to Top $6 Billion in Second Quarter, an Industrial Info Market Brief
North American Pharma-Biotech Construction Starts to Top $6 Billion in Second Quarter, an Industrial Info Market Brief
Attachment: PharmaBio 0220
Capital construction starts at North America's pharmaceutical and biotech facilities remain strong in the second quarter of 2020. Industrial Info is tracking 185 capital projects, with a total investment value (TIV) of $6.23 billion, which are slated to kick off from April to June 2020.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- France Plans $55 Billion in Windfarms as Offshore Projects Gain Momentum
- Africa's Fertilizer Demand Sparks $5.8 Billion of Projects
- Poland's PGE Plans $7 Billion Renewable Energy Push
- Peru's Runoff Presidential Election Could Impact $45 Billion in Mining Proj...
- Industrial Construction Activity Up 37% So Far in 2021
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
